NEW
Font size
WorksheetsThe First 1000 Days: Microbiota, Immunity & Nutrition in Motion
Total questions: 13
Worksheet time: 10mins
Human Milk Oligosaccharides (HMOs) in Infant Nutrition
•A. HMOs provide direct caloric energy to infants and are a major source of essential amino acids.
•B. HMOs enhance pathogen clearance by boosting IgE-mediated hypersensitivity responses.
•C. HMOs promote growth of beneficial gut microbiota, inhibit pathogen adhesion, and support mucosal immune development.
•D. HMOs suppress the maturation of intestinal microbiota to preserve neonatal gut sterility.
•E. HMOs are digested and absorbed in the small intestine, providing early immune training through systemic circulation.
Mechanistic basis and clinical correlation
•A. They serve as a direct energy source for enterocytes, reducing NEC and promoting epithelial proliferation.
•B. They increase antigen presentation by dendritic cells, enhancing IgE production and reducing food allergies.
•C. They promote colonization of beneficial bacteria, stimulate regulatory T cells, and reduce risk of respiratory, urinary, and GI
•D. They enhance neutrophil chemotaxis and reactive oxygen species (ROS) production, directly killing pathogens and lowering sepsis risk.
•E. They delay gut microbiota maturation, favoring anaerobic over aerobic species to reduce allergy prevalence.
Development of taste and texture
•A. Delaying the introduction of lumpy textures until after 12 months reduces choking risk and improves long-term vegetable intake.
•B. Early exposure to a narrow range of bland tastes reduces food fussiness by reinforcing familiar preferences.
•C. Introducing a variety of textures before 10 months supports oral motor development and increases acceptance of complex foods later.
•D. Genetic predisposition to taste preferences is unmodifiable, making environmental exposure during infancy relatively ineffective.
•E. Starting with thin gruels is ideal in Indian infants due to cultural acceptability and higher caloric density.
Y Y paradox
•A. The child's elevated cardiometabolic risk is unexpected given his low BMI and must be primarily due to genetic predisposition.
•B. Low BMI combined with central adiposity reflects an adaptive fetal programming response to early-life undernutrition.
•C. Metabolic risk in Indian children is negligible unless obesity coexists with high BMI and waist circumference.
•D. This phenotype is a transient feature that resolves with adequate caloric intake during adolescence.
•E. The paradox is due to excessive maternal weight gain during pregnancy and overnutrition in infancy.
Infant and child feeding index
•Score = 9; reflects optimal feeding practices and indicates no nutritional intervention is needed
•Score = 8; feeding practices are optimal, though anthropometric monitoring should continue due to underweight status
•Score = 6; moderate feeding practices; nutritional counseling should focus on increasing dietary diversity
•Score = 7; moderate practices; current feeding is sufficient for age and no further action is required
•Score = 5; poor feeding practices; urgent nutritional supplementation is needed
Micronutrient deficiency in Indian Children
•A. Iron deficiency is uncommon in toddlers with a predominantly vegetarian diet due to higher phytate content, which enhances absorption.
•B. Vitamin A deficiency is largely eliminated in India due to widespread availability of green leafy vegetables.
•C. Micronutrient deficiency syndromes often coexist and are more prevalent in under-resourced and tribal populations despite national supplementation programs.
•D. Universal salt iodization has fully addressed iodine deficiency, making it an unlikely cause of neurodevelopmental delay in rural Indian children.
•E. Zinc deficiency rarely contributes to stunting or infections and is generally overestimated in national estimates.
Nutrition Education and Complementary Feeding Interventions
•A. No improvement in weight-for-age or height-for-age, but significant reductions in respiratory illness
•B. Modest improvements in growth parameters but no change in morbidity indicators
•C. Modest gains in weight and height Z-scores and reduced risk of diarrhea with potential added benefit for respiratory infections
•D. Strong improvements in linear growth, but increased incidence of infections due to diet changes
•E. Improved morbidity outcomes only if fortified foods are used, regardless of education or hygiene practices
Microbiota Development in Early Life
•A. Early formula feeding accelerates Firmicutes dominance and prevents persistence of facultative anaerobes like Enterobacteriaceae
•B. Cesarean delivery is associated with earlier Bacteroides colonization due to exposure to environmental flora
•C. Antibiotic exposure may cause regression in microbial maturation, leading to sustained low diversity and immune dysregulation
•D. Introduction of complex carbohydrates is unlikely to influence the gut microbiota until after 36 months of age
•E. Prolonged presence of Enterobacteriaceae in the stable phase is a marker of healthy microbial succession
Introduction of allergenic foods
•A) Delay until after 9 months and after measles vaccination
•B) Avoid completely
•C) Introduce one at a time from 6 months onward
•D) Only introduce after 2 years of age
Iron-Fortified Cereal and Anemia Prevention in Indian Infants
•A) No change in hemoglobin levels or anemia prevalence
•B) Lower anemia prevalence (23% vs. 45%) and higher mean hemoglobin (118.1 g/L vs. 109.5 g/L)
•C) Significantly improved growth Z-scores but no neurodevelopmental impact
•D) Higher rates of iron deficiency compared to the control group
Baby led weaning
•A) It has a high incidence of choking
•B) It may result in inadequate nutrient intake or choking if not done carefully
•C) It is only recommended if traditional complementary feeding method fails
•D) It guarantees prevention of obesity
Early Gut Microbiome and Long-Term Health
•A. Early dysbiosis only affects short-term infection risk and has no documented role in neurodevelopment or metabolism.
•B. Early-life microbial disruption may epigenetically reprogram immune and metabolic pathways, increasing risk for allergies, obesity, and neurodevelopmental disorders.
•C. Gut microbiota changes normalize by age 3, nullifying their long-term influence on cardiovascular or inflammatory disease risk.
•D. Formula feeding and C-section delivery enhance microbiota diversity, improving gut barrier function and reducing inflammatory risk.
•E. The primary impact of early microbiome modulation is limited to gastrointestinal tract diseases, such as diarrhea or colic, without systemic implications.
Early-Life Gut Microbiome and Chronic Disease Risk
•A. Parkinson’s disease, via altered cortisol metabolism and adrenal dysregulation
•B. Autism spectrum disorder, via microbial metabolite modulation of the gut-brain axis
•C. Type 1 diabetes, via insulin receptor desensitization caused by altered SCFA levels
•D. Obesity, via post-pubertal changes in growth hormone and adiponectin interactions
•E. Alzheimer’s disease, via direct pathogenic invasion of the CNS by gut bacteria
